Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Regencell Bioscience Holdings Ltd (NASDAQ: RGC) closed the day trading at $41.00 down -30.07% from the previous closing price of $58.63. In other words, the price has decreased by -$30.07 from its previous closing price. On the day, 0.68 million shares were traded. RGC stock price reached its highest trading level at $69.0 during the session, while it also had its lowest trading level at $40.53.
Ratios:
For a better understanding of RGC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 41.92 and its Current Ratio is at 41.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGC now has a Market Capitalization of 533528896 and an Enterprise Value of 525652000.
Stock Price History:
The Beta on a monthly basis for RGC is -7.00, which has changed by 10.884058 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, RGC has reached a high of $64.72, while it has fallen to a 52-week low of $3.03. The 50-Day Moving Average of the stock is 375.05%, while the 200-Day Moving Average is calculated to be 506.54%.
Shares Statistics:
Over the past 3-months, RGC traded about 644.63K shares per day on average, while over the past 10 days, RGC traded about 3840850 shares per day. A total of 13.01M shares are outstanding, with a floating share count of 0.80M. Insiders hold about 93.84% of the company’s shares, while institutions hold 0.24% stake in the company. Shares short for RGC as of 1740700800 were 3918 with a Short Ratio of 0.01, compared to 1738281600 on 21712. Therefore, it implies a Short% of Shares Outstanding of 3918 and a Short% of Float of 0.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
